Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
9641809
Reference Type
Journal Article
Subtype
Review
Title
Organic anion-transporting polypeptide (OATP) transporter family and drug disposition
Author(s)
Kim, RB
Year
2003
Is Peer Reviewed?
Yes
Journal
European Journal of Clinical Investigation
ISSN:
0014-2972
EISSN:
1365-2362
Volume
33 Suppl 2
Page Numbers
1-5
Language
English
PMID
14641549
DOI
10.1046/j.1365-2362.33.s2.5.x
Abstract
Drug transporters are increasingly recognized as a key determinant of drug disposition. Recent studies have revealed that targeted expression of drug uptake and efflux transporters to specific cell membrane domains allows for the efficient directional movement of many drugs in clinical use. While the role of certain efflux transporters such as MDR1 (P-glycoprotein) in drug disposition has been extensively studied, emerging evidence suggests that uptake transporters may also be important to the intestinal absorption and renal or hepatic elimination of drugs. Members of the organic anion-transporting polypeptide (OATP) family of drug uptake transporters have been found capable of transporting a large array of structurally divergent drugs. Moreover, expression of OATP isoforms in the gastrointestinal tract, liver and kidney, as well as at the level of the blood-brain barrier, has important implications for our understanding of the factors governing drug absorption, elimination and tissue penetration.
Tag
PFAS
•
PFOA and PFOS OW MCLG Approaches
Cited in White Papers
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity